185 related articles for article (PubMed ID: 23494829)
1. Transplantation for refractory germ cell tumors: does it really make a difference?
Nieto Y
Curr Oncol Rep; 2013 Jun; 15(3):232-8. PubMed ID: 23494829
[TBL] [Abstract][Full Text] [Related]
2. [High-dose chemotherapy with transplantation of autologous stem cells in advanced germ-cell poor-risk testicular tumors].
May M; Georgieva G; Gunia S; Peter N; Steinhauer HB; Hoschke B
Urologiia; 2007; (2):58-63. PubMed ID: 17578200
[TBL] [Abstract][Full Text] [Related]
3. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL
Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Autologous Stem Cell Transplantation (ASCT) in Relapsed/Refractory Germ Cell Tumors: Single Center Experience from Turkey.
Yildiz F; Durnali A; Eraslan E; Ilhan A; Tufan G; Aslan F; Arslan UY; Alkis N; Demirci U; Altuntas F; Oksuzoglu B
Urol J; 2020 Aug; 17(5):497-500. PubMed ID: 32869258
[TBL] [Abstract][Full Text] [Related]
5. Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT).
De Giorgi U; Richard S; Badoglio M; Kanfer E; Bourrhis JH; Nicolas-Virelizier E; Vettenranta K; Lioure B; Martin S; Dreger P; Schuler MK; Thomson K; Scarpi E; Rosti G; Selle F; Mangili G; Lanza F; Bregni M;
Ann Oncol; 2017 Aug; 28(8):1910-1916. PubMed ID: 28510616
[TBL] [Abstract][Full Text] [Related]
6. Management of recurrent testicular germ cell tumors.
Sonpavde G; Hutson TE; Roth BJ
Oncologist; 2007 Jan; 12(1):51-61. PubMed ID: 17227900
[TBL] [Abstract][Full Text] [Related]
7. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
Broun ER; Nichols CR; Turns M; Williams SD; Loehrer PJ; Roth BJ; Lazarus HM; Einhorn LH
Cancer; 1994 Mar; 73(6):1716-20. PubMed ID: 7512438
[TBL] [Abstract][Full Text] [Related]
8. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
[TBL] [Abstract][Full Text] [Related]
9. An overview of high dose chemotherapy with autologous stem cell rescue for germ cell tumors in current practice.
Ozaydın S; Sahin U; Karadurmus N; Arpaci F; Demirer T
J BUON; 2017; 22(2):306-311. PubMed ID: 28534349
[TBL] [Abstract][Full Text] [Related]
10. Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
Lorch A; Kleinhans A; Kramar A; Kollmannsberger CK; Hartmann JT; Bokemeyer C; Rick O; Beyer J
J Clin Oncol; 2012 Mar; 30(8):800-5. PubMed ID: 22291076
[TBL] [Abstract][Full Text] [Related]
11. [High-dose chemotherapy and residual tumor resection in male germ cell tumors].
Lorch A; Albers P; Winter C; Beyer J
Urologe A; 2011 Sep; 50(9):1047-54. PubMed ID: 21845425
[TBL] [Abstract][Full Text] [Related]
12. Role of autologous bone marrow transplantation in germ-cell cancer.
Droz JP; Pico JL; Kramar A
Urol Clin North Am; 1993 Feb; 20(1):161-71. PubMed ID: 8381996
[TBL] [Abstract][Full Text] [Related]
13. Management of poor-prognosis or relapsed germ-cell cancer.
Daugaard G
BJU Int; 2009 Nov; 104(9 Pt B):1392-7. PubMed ID: 19840019
[No Abstract] [Full Text] [Related]
14. Pharmacotherapy of relapsed metastatic testicular cancer.
Kollmannsberger C; Honecker F; Bokemeyer C
Expert Opin Pharmacother; 2008 Sep; 9(13):2259-72. PubMed ID: 18710351
[TBL] [Abstract][Full Text] [Related]
15. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY
Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340
[TBL] [Abstract][Full Text] [Related]
16. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
Narayan V; Gunnarsson O; Hwang WT; Squillante CM; Nathanson KL; Stadtmauer EA; Vaughn DJ
Clin Genitourin Cancer; 2016 Dec; 14(6):524-529. PubMed ID: 27083130
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy for male germ cell tumor.
Hara I; Miyake H; Yamada Y; Takenaka A; Fujisawa M
Int J Urol; 2006 Aug; 13(8):1037-44. PubMed ID: 16903926
[TBL] [Abstract][Full Text] [Related]
19. Testicular tumors: delay in diagnosis and influence on survival.
Prout GR; Griffin PP
Am Fam Physician; 1984 May; 29(5):205-9. PubMed ID: 6328963
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]